Daewon Pharmaceutical Co Ltd banner

Daewon Pharmaceutical Co Ltd
KRX:003220

Watchlist Manager
Daewon Pharmaceutical Co Ltd Logo
Daewon Pharmaceutical Co Ltd
KRX:003220
Watchlist
Price: 11 430 KRW -0.95% Market Closed
Market Cap: ₩256.4B

Wall Street
Price Targets

Price Targets Summary
Daewon Pharmaceutical Co Ltd

Wall Street analysts forecast Daewon Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Daewon Pharmaceutical Co Ltd is 16 320 KRW with a low forecast of 16 160 KRW and a high forecast of 16 800 KRW.

Lowest
Price Target
16 160 KRW
41% Upside
Average
Price Target
16 320 KRW
43% Upside
Highest
Price Target
16 800 KRW
47% Upside
Daewon Pharmaceutical Co Ltd Competitors:
Price Targets
JNJ
Johnson & Johnson
-5% Downside
U10
UOB-Kay Hian Holdings Ltd
-1% Downside
LE
Lands End Inc
124% Upside

Revenue
Forecast

12% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Daewon Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

6% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
6% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Daewon Pharmaceutical Co Ltd's operating income is 6%. The projected CAGR for the next 3 years is 1%.

Net Income
Forecast

3% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
3% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 13 years the compound annual growth rate for Daewon Pharmaceutical Co Ltd's net income is 3%. The projected CAGR for the next 3 years is 8%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Daewon Pharmaceutical Co Ltd's stock price target?
Price Target
16 320 KRW

According to Wall Street analysts, the average 1-year price target for Daewon Pharmaceutical Co Ltd is 16 320 KRW with a low forecast of 16 160 KRW and a high forecast of 16 800 KRW.

What is Daewon Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Daewon Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 6%.

What is Daewon Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Daewon Pharmaceutical Co Ltd's operating income is 6%. The projected CAGR for the next 3 years is 1%.

What is Daewon Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Daewon Pharmaceutical Co Ltd's net income is 3%. The projected CAGR for the next 3 years is 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett